News

Ranbaxy is recalling Pravastatin 10mg tablets of batch number 2131768 and Pravastatin 40mg Tablets of batch numbers 2117477 and 2129684. Some of safety warnings were mandatory and initiated

The multi-centre, randomised, open-label single, subcutaneous dose Phase II trial was designed assess safety, pharmacodynamics and pharmacokinetics in chronic kidney disease patients not on dialysis. The study, which

Safyral raises the folate levels in women who choose OC for birth control for the purpose of reducing the risk of rare neural tube defects (NTDs) in a

NRCC, which was established in 1998, has been operated by Vertellus as a joint venture with the Nantong Acetic Acid Chemical Corporation (NAACC). Sole control of the facility

In addition to the three new collaborations, Adimab has also reached a technical milestone in its ongoing collaboration with Novartis, which was initiated in June of 2010. Under

The pilot study will enroll 20 patients with existing chronic wounds, who will be monitored over a 42-day period in order to evaluate the effectiveness of dCELL Human

The foundation will now support the development of the PD01 vaccine by AFFiRiS with $475,000. AFFiRiS said that the vaccine PD01 targets the protein known as alpha-synuclein (alpha-syn),

The goal of the project is to develop high affinity and renewable reagents to capture tryptic peptides derived from human plasma protein biomarkers, and then use the captured

As per the terms of the acquisition, Atrium acquired Minami for a total cash consideration of EUR5.5m ($7.38m) before a revenue earn-out payment of up to EUR2m ($2.68m)